Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.62 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.62 |
| ▸ | TSHR | P16473 | 3/20 | 0.54 |
| ▸ | CA2 | P00918 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | LMNA | P02545 | 4/20 | 0.53 |
| ▸ | HPGD | P15428 | 4/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.53 |
| ▸ | CA4 | P22748 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | EGFR | P00533 | 2/20 | 0.53 |
| ▸ | FYN | P06241 | 2/20 | 0.53 |
| ▸ | MMP9 | P14780 | 2/20 | 0.53 |
| ▸ | RECQL | P46063 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30194816 | 1.00 | GABRA1 (0.62) | GABRA1GABRB2TSHRCA2ALDH1A1 | |
| SCHEMBL11510892 | 0.84 | GABRA1 (0.52) | GABRA1GABRB2TSHRCA2ALDH1A1 | |
| SCHEMBL671174 | 0.84 | GABRA1 (0.65) | GABRA1GABRB2TSHRCA2ALDH1A1 | |
| SCHEMBL11125456 | 0.84 | GABRA1 (0.52) | GABRA1GABRB2TSHRCA2ALDH1A1 | |
| SCHEMBL11510792 | 0.84 | GABRA1 (0.52) | GABRA1GABRB2TSHRCA2ALDH1A1 | |
| SCHEMBL30195663 | 0.81 | GABRA1 (0.62) | GABRA1GABRB2TSHRCA2ALDH1A1 | |
| SCHEMBL11504087 | 0.81 | GABRA1 (0.62) | GABRA1GABRB2TSHRCA2ALDH1A1 | |
| SCHEMBL78917 | 0.81 | GABRA1 (0.62) | GABRA1GABRB2TSHRCA2ALDH1A1 | |
| SCHEMBL29407501 | 0.81 | GABRA1 (0.62) | GABRA1GABRB2TSHRCA2ALDH1A1 | |
| SCHEMBL19223968 | 0.80 | TSHR (0.44) | GABRA1GABRB2TSHRCA2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 273 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200316550-A1 | THIOL-EPOXY BASED AEROGELS | HENKEL AG & CO KGAA (DE) | 2020-10-08 | — | — | US | claimed |
| US-7884172-B2 | epoxy resin is obtained by glycidylating one or more phenol compounds comprising 95% or more 1,1,2,2-tetrakis(hydroxyphenyl)ethane; forms cured object having high heat resistance, which is improved in impact resistance and moisture resistance | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2011-02-08 | — | — | US | claimed |
| US-20090131607-A1 | Epoxy Resin, Epoxy Resin Composition, Photosensitive Resin Composition and Cured Object Obtained Therefrom | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-05-21 | — | — | US | claimed |
| EP-1939233-A1 | EPOXY RESIN, EPOXY RESIN COMPOSITION, PHOTOSENSITIVE RESIN COMPOSITION, AND CURED OBJECT OBTAINED THEREFROM | Nippon Kayaku Kabushiki Kaisha (JP) | 2008-07-02 | — | — | EP | claimed |
| US-7049388-B2 | Process for manufacturing an α-dihydroxy derivative and epoxy resins prepared therefrom | DOW GLOBAL TECHNOLOGIES INC. (US) | 2006-05-23 | — | — | US | claimed |
| US-20060074149-A1 | Process for manufacturing an alpha-dihydroxy derivative and epoxy resins prepared therefrom | BORIACK CLINTON J | 2006-04-06 | — | — | US | claimed |
| EP-1080084-B1 | PROCESS FOR EPOXIDATION OF ARYL ALLYL ETHERS | DOW GLOBAL TECHNOLOGIES INC (US) | 2004-05-06 | — | — | EP | claimed |
| US-20040049004-A1 | Process for manufacturing an alpha-dihydroxy derivative and epoxy resins prepared therefrom | THE DOW CHEMICAL COMPANY | 2004-03-11 | — | — | US | claimed |
| US-6646102-B2 | Epoxidizing an alpha - halohydrin intermediate produced from a halide substitution of an alpha -dihydroxy derivative which has been obtained by a dihydroxylation reaction of an aryl allyl ether, oxidation catalysts | DOW GLOBAL TECHNOLOGIES INC. | 2003-11-11 | — | — | US | claimed |
| US-20030105268-A1 | Process for manufacturing an alpha-dihydroxy derivative and epoxy resins prepared therefrom | DOW GLOBAL TECHNOLOGIES INC. | 2003-06-05 | — | — | US | claimed |
| US-5102972-A | Noncrosslinked addition polymers of di ortho-substituted bismaleimides; fracture toughness; extension by noncatalytic Michael condensation | ALLIED-SIGNAL INC. (US) | 1992-04-07 | — | — | US | claimed |
| EP-0456717-A1 | POLYHYDRIC PHENOLS AS CHAIN EXTENDERS FOR CERTAIN BISMALEIMIDE RESINS | AlliedSignal Inc. (US) | 1991-11-21 | — | — | EP | claimed |
| WO-1990008796-A1 | POLYHYDRIC PHENOLS AS CHAIN EXTENDERS FOR CERTAIN BISMALEIMIDE RESINS | ALLIED-SIGNAL INC. (US) | 1990-08-09 | — | — | WO | claimed |
| EP-0181832-B1 | SELF-EXTINGUISHING EPOXYRESIN MOULDING MASSES, RESISTANT TO TRACKING, AND THEIR USE | CIBA-GEIGY AG (CH) | 1989-11-08 | — | — | EP | claimed |
| US-4668718-A | Self-extinguishing, track-resistant epoxy resin moulding composition and use thereof | CIBA-GEIGY CORPORATION (US) | 1987-05-26 | — | — | US | claimed |
| US-4246394-A | PROMOTER FOR CROSSLINKING | VEBA-CHEMIE AKTIENGESELLSCHAFT (DE) | 1981-01-20 | — | — | US | claimed |
| JP-5201902-A | — | — | None | — | — | JP | disclosed |
| US-12616995-B2 | Methods for producing overt security features exhibiting one or more indicia | SICPA HOLDING SA (CH) | 2026-05-05 | — | — | US | disclosed |
| US-4119586-A | Polymer/polyol compositions, processes for making same and processes for making polyurethane products therefrom | UNION CARBIDE CORPORATION (US) | 1978-10-10 | — | — | US | disclosed |
| US-RE28715-E | UNSATURATED MONOMERS AND POLYOLS | Stamberger, Paul (US) | 1976-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12616995-B2 | Methods for producing overt security features exhibiting one or more indicia | ATG4B, TPM4, ATG4A | GABRA1 1093/4885GABRB2 747/4885TSHR 416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.